These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21521559)

  • 1. 99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin αVβ3 expression.
    Zhou Y; Kim YS; Chakraborty S; Shi J; Gao H; Liu S
    Mol Imaging; 2011 Oct; 10(5):386-97. PubMed ID: 21521559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
    Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
    Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
    Zhou Y; Kim YS; Lu X; Liu S
    Bioconjug Chem; 2012 Mar; 23(3):586-95. PubMed ID: 22369387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.
    Ji S; Czerwinski A; Zhou Y; Shao G; Valenzuela F; Sowiński P; Chauhan S; Pennington M; Liu S
    Mol Pharm; 2013 Sep; 10(9):3304-14. PubMed ID: 23875883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
    Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
    Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.
    Zheng Y; Ji S; Czerwinski A; Valenzuela F; Pennington M; Liu S
    Bioconjug Chem; 2014 Nov; 25(11):1925-41. PubMed ID: 25312799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
    Wang L; Shi J; Kim YS; Zhai S; Jia B; Zhao H; Liu Z; Wang F; Chen X; Liu S
    Mol Pharm; 2009; 6(1):231-45. PubMed ID: 19067525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
    Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S
    Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides.
    Yang Y; Ji S; Liu S
    Bioconjug Chem; 2014 Sep; 25(9):1720-9. PubMed ID: 25144854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.
    Ji S; Zhou Y; Shao G; Liu S
    Bioconjug Chem; 2013 Apr; 24(4):701-11. PubMed ID: 23521129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.
    Ji S; Zhou Y; Voorbach MJ; Shao G; Zhang Y; Fox GB; Albert DH; Luo Y; Liu S; Mudd SR
    J Pharmacol Exp Ther; 2013 Aug; 346(2):251-8. PubMed ID: 23750021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression.
    Jia B; Shi J; Yang Z; Xu B; Liu Z; Zhao H; Liu S; Wang F
    Bioconjug Chem; 2006; 17(4):1069-76. PubMed ID: 16848417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.
    Shi J; Wang L; Kim YS; Zhai S; Jia B; Wang F; Liu S
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1874-84. PubMed ID: 19484236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers.
    Shi J; Wang L; Kim YS; Zhai S; Liu Z; Chen X; Liu S
    J Med Chem; 2008 Dec; 51(24):7980-90. PubMed ID: 19049428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.
    Fu T; Qu W; Qiu F; Li Y; Shao G; Tian W; Hua Z; Zhang Y; Wang F
    Cancer Biother Radiopharm; 2014 Nov; 29(9):351-8. PubMed ID: 25286251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.
    Liu S; Hsieh WY; Kim YS; Mohammed SI
    Bioconjug Chem; 2005; 16(6):1580-8. PubMed ID: 16287258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics.
    Shi J; Kim YS; Chakraborty S; Jia B; Wang F; Liu S
    Bioconjug Chem; 2009 Aug; 20(8):1559-68. PubMed ID: 19603780
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.